Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Phase II Study to Assess the Efficacy and Safety of Topical SR-T100® Gel in the Treatment of Human Cutaneous Squamous Cell Carcinoma in Situ (Actinic Keratosis and Bowen's Disease)

NCT02085395 is registered in ClinicalTrials.gov with G&E Herbal Biotechnology Co., LTD as lead sponsor.

NCT NCT02085395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02085395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Phase II Study to Assess the Efficacy and Safety of Topical SR-T100® Gel in the Treatment of Human Cutaneous Squamous Cell Carcinoma in Situ (Actinic Keratosis and Bowen's Disease)
Lead sponsor
G&E Herbal Biotechnology Co., LTD
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
November 30, 2010
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis, bowen's disease